SCI and Stem Cell Clinical Trials: What’s the Latest?

In this Google Hangout, Jane Lebkowski, PhD, president of research and development at Asterias Biotherapeutics, and Kevin Whittlesey, PhD, a CIRM science officer discuss the latest progress in stem cell-based research for treatment of spinal cord injury. Asterias has a $14 million CIRM grant to support their embryonic stem cell-based clinical trial for spinal cord injury. Kevin McCormack, CIRM’s Director of Public Communications, moderated the conversation.

This entry was posted in Chronic Spinal Cord Injury Research, Regenerative Medicine, Spinal Research, Stem Cell Research and tagged , , , , . Bookmark the permalink.